価格表

在庫・価格 : 2025年04月26日 19時27分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Carbonic Anhydrase IX (CA IX), Rabbit-Poly
データシート※最新のデータシートでない場合があります
NB100-417SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥55,000
(未発注)
追加

在庫・価格 : 2025年04月26日 19時27分 現在

Anti-Carbonic Anhydrase IX (CA IX), Rabbit-Poly

  • 商品コード:NB100-417SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥55,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yoo H et al. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin. Cancer Res. 2007 Jan;13(1):68-75
Yoo H et al
2007/01/01
PubMed
2 Sathornsumetee S et al. Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J. Clin. Oncol. 2008 Jan;26(2):271-8
Sathornsumetee S et al
2008/01/01
PubMed
3 Kang HJ et al. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma. Virchows Arch. 2015 Jan;
Kang HJ et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
4 Lin XY et al. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology. Histopathology 2015 Apr;66(5):685-94
Lin XY et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
5 Motzer RJ et al. Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma. Cancer Chemother. Phar
Motzer RJ et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
6 Gellert LL et al. The diagnostic accuracy of percutaneous renal needle core biopsy and its potential impact on the clinical management of renal cortical neoplasms. Arch. Pathol. Lab. Med. 2014 Dec;138(12):1673-9
Gellert LL et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
7 Pellegrini L et al. SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ 2012 May;
Pellegrini L et al
2012/01/01
Species: Human, Applications: WB PubMed
8 Mackenzie KA et al. Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Histopathology 2011 May;58(6):875-85
Mackenzie KA et al
2011/01/01
Species: Human, Applications: IHC PubMed
9 Weber DC et al. The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy. Radiat Oncol 2012;7:66
Weber DC et al
2012/01/01
Species: Human, Applications: IHC PubMed
10 Deschamps L et al. The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum. Neuroendocrinology 2012;95(3):214-22
Deschamps L et al
2012/01/01
Species: Human, Applications: IHC PubMed
11 Lapinski JE et al. Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers. Appl. Immunohistochem. Mol. Morphol. 2010 Oct;18(5):414-21
Lapinski JE et al
2010/01/01
Species: Human, Applications: IHC PubMed
12 Currie MJ et al. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Hum. Pathol. 2012 Oct;
Currie MJ et al
2012/01/01
Species: Human, Applications: IHC PubMed
13 Lee HJ et al. Inhibition of vascular endothelial growth factor a and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int. J. Radiat. Oncol. Biol. Phys. 2015 Mar;91(3):6
Lee HJ et al
2015/01/01
Applications: PubMed
14 Pinato DJ et al. Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations. Br. J. Cancer 2013 Feb;108(2):429-37
Pinato DJ et al
2013/01/01
Species: Human, Applications: IHC PubMed
15 Muriel L坦pez C et al. Predictive factors for response to treatment in patients with advanced renal cell carcinoma. Invest New Drugs 2012 May;
Muriel L坦pez C et al
2012/01/01
Species: Human, Applications: IHC PubMed
16 Van den Eynden GG et al. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Br. J. Cancer 2005 Nov;93(10):1128-36
Van den Eynden GG et al
2005/01/01
Species: Human, Applications: IHC-P PubMed
17 M端ller J. [Recent evaluation of a Candida hemagglutination test]. Mycoses 1991;34 Suppl 1:63-7
M端ller J
1991/01/01
Species: Human, Applications: IHC-P PubMed
18 Park I et al. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med 2013 Jul;70(1):33-9
Park I et al
2013/01/01
Species: Rat, Applications: IHC-P PubMed
19 Cho SY et al. Activation of AMP-Activated Protein Kinase α and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells. Evid Based Complement Alternat Med 2013;2013:974313
Cho SY et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
20 Matsumura Y et al. Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis. Cancer Sci 2012 Mar;
Matsumura Y et al
2012/01/01
Species: Human, Applications: IHC PubMed
21 Dubois L et al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: A new concept of dual targeting drugs. Radiother Oncol 2013 Jul;
Dubois L et al
2013/01/01
Species: Mouse, Applications: IHC-Fr PubMed
22 Garcia-Parra R et al. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Eur. J. Nucl. Med. Mol. Imaging 2011 Oct;38(10):1816-23
Garcia-Parra R et al
2011/01/01
Species: Human, Applications: IHC-P PubMed
23 Ogino T et al. Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions. Cancer Immunol. Immunother. 2012 Mar;61(3):409-24
Ogino T et al
2012/01/01
Applications: PubMed
24 Onishi H et al. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer. Cancer Sci 2012 Apr;
Onishi H et al
2012/01/01
Species: Mouse, Applications: IHC, ICC/IF PubMed
25 Pinato DJ et al. An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes. Br. J. Cancer 2014 Jan;110(1):115-22
Pinato DJ et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
26 Zhang Q et al. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis 2013 Mar;
Zhang Q et al
2013/01/01
Species: Human, Applications: WB PubMed
27 Santos CD et al. Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma. Br. J. Cancer 2015 Jan;112(1):86-94
Santos CD et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
28 Piao Y et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro-oncology 2012 Nov;14(11):1379-92
Piao Y et al
2012/01/01
Species: Human, Mouse, Applications: IHC PubMed
29 Yin S et al. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP. Clin. Cancer Res. 2012 Dec;18(24):6623-33
Yin S et al
2012/01/01
Species: Human, Applications: WB PubMed
30 Eguchi D et al. Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. J Surg Res 2012 Jul;
Eguchi D et al
2012/01/01
Species: Human, Applications: IHC PubMed
31 Sadlecki P et al. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients. Biomed Res Int 2014;2014:616850
Sadlecki P et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
32 Li Y et al. Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells. Biochim. Biophys. Acta 2011 Jan;1813(1):159-67
Li Y et al
2011/01/01
Species: Human, Applications: WB PubMed
33 Westbury CB et al. Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. Br J Radiol 2007 Nov;80(959):934-8
Westbury CB et al
2007/01/01
Species: Human, Applications: IHC-P PubMed
34 Carbonell WS et al. β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Res. 2013 May;73(10):3145-54
Carbonell WS et al
2013/01/01
Species: Human, Applications: IHC-P, ICC/IF PubMed
35 Albert S et al. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol. 2012 Jul;
Albert S et al
2012/01/01
Applications: PubMed
36 Brouillet S et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell. Mol. Life Sci. 2012 Sep;
Brouillet S et al
2012/01/01
Species: Human, Applications: IHC PubMed
37 Wang Y et al. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc. Natl. Acad. Sci. U.S.A. 2012 Mar;109(13):4892-7
Wang Y et al
2012/01/01
Species: Human, Applications: EMSA, WB PubMed
38 Jung JH et al. Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer. J. Gastroenterol. 2012 Jan;47(1):37-48
Jung JH et al
2012/01/01
Species: Human, Applications: WB PubMed
39 Kumar S et al. Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts. Transl Oncol 2013 Aug;6(4):493-503
Kumar S et al
2013/01/01
Species: Human, Applications: IHC PubMed
40 Kwon OJ et al. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma. Head Neck 2014 Feb;
Kwon OJ et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
41 Chaumeil MM et al. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage 2012 Jan;59(1):193-201
Chaumeil MM et al
2012/01/01
Species: Rat, Applications: IHC-P PubMed
42 Chamboredon S et al. Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells. Mol. Biol. Cell 2011 Sep;22(18):3366-78
Chamboredon S et al
2011/01/01
Species: Human, Applications: WB PubMed
43 Al-Ahmadie HA et al. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am. J. Surg. Pathol. 2011 Jul;35(7):949-61
Al-Ahmadie HA et al
2011/01/01
Species: Human, Applications: IHC PubMed
44 Lucio-Eterovic AK et al. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin. Cancer Res. 2009 Jul;15(14):4589-99
Lucio-Eterovic AK et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
45 Pistollato F et al. Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells 2010 Nov;28(11):1918-29
Pistollato F et al
2010/01/01
Species: Human, Applications: IHC-P PubMed
46 Gauter-Fleckenstein B et al. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 2008 Mar;44(6):982-9
Gauter-Fleckenstein B et al
2008/01/01
Species: Rat, Applications: IHC-P PubMed
47 Sakata K et al. Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers. Jpn. J. Clin. Oncol. 2008 Jun;38(6):402-7
Sakata K et al
2008/01/01
Species: Human, Applications: IHC-P PubMed
48 Speisky D et al. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients. Clin. Cancer Res. 2012 May;18(10):2838-49
Speisky D et al
2012/01/01
Species: Human, Applications: IHC PubMed
49 El-Heliebi A et al. Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer? J Transl Med 2013;11:214
El-Heliebi A et al
2013/01/01
Species: Human, Applications: ICC/IF PubMed
50 Atkins M et al. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin. Cancer Res. 2005 May;11(10):3714-21
Atkins M et al
2005/01/01
Species: Human, Applications: IHC PubMed
51 Wen YA et al. Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells. Mol. Cell. Biol. 2013 Nov;33(22):4594-605
Wen YA et al
2013/01/01
Species: Human, Applications: WB PubMed
52 Fromy B et al. Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers. Nat Med 2012 Jul;
Fromy B et al
2012/01/01
Species: Mouse, Applications: IHC PubMed
53 Kato Y et al. Expression of a hypoxia-associated protein, carbonic anhydrase-9, correlates with malignant phenotypes of gastric carcinoma. Digestion 2010;82(4):246-51
Kato Y et al
2010/01/01
Species: Human, Applications: IHC PubMed
54 Kaidi A et al. Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia? Gut 2007 Nov;56(11):1637-8
Kaidi A et al
2007/01/01
Species: Human, Applications: IHC-P PubMed
55 Lim CS et al. Increased activation of the hypoxia-inducible factor pathway in varicose veins. J. Vasc. Surg. 2012 May;55(5):1427-39
Lim CS et al
2012/01/01
Species: Human, Applications: WB PubMed
56 Janmohamed SR et al. Support for the hypoxia theory in the pathogenesis of infantile haemangioma. Clin. Exp. Dermatol. 2014 Dec;
Janmohamed SR et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
57 Aarntzen EH et al. Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells. Clin. Cancer Res. 2013 Mar;19(6):1525-1533
Aarntzen EH et al
2013/01/01
Species: Human, Applications: IHC PubMed
58 Loinard C et al. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 2009 Jul;120(1):50-9
Loinard C et al
2009/01/01
Species: Human, Mouse, Applications: WB PubMed
59 Pistollato F et al. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 2010 May;28(5):851-62
Pistollato F et al
2010/01/01
Species: Human, Applications: IHC-P PubMed
60 Bussolati B et al. Renal CD133+/CD73+ Progenitors Produce Erythropoietin under Hypoxia and Prolyl Hydroxylase Inhibition. J. Am. Soc. Nephrol. 2013 Jul;24(8):1234-41
Bussolati B et al
2013/01/01
Applications: PubMed
61 Ba単uelos CA et al. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation. Clin. Cancer Res. 2009 May;15(10):3344-53
Ba単uelos CA et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
62 Chen LQ et al. Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models. Leuk. Lymphoma 2014 Nov;:1-8
Chen LQ et al
2014/01/01
Applications: PubMed
63 Chen J et al. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am. J. Pathol. 2009 Jul;175(1):400-11
Chen J et al
2009/01/01
Species: Mouse, Applications: IHC-P PubMed
64 Hwa JS et al. The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014 Aug;
Hwa JS et al
2014/01/01
Applications: PubMed
65 Engler JR et al. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. PLoS ONE 2012;7(8):e43339
Engler JR et al
2012/01/01
Species: Human, Applications: IHC PubMed
66 Guise CP et al. Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxia. Mol. Pharmacol. 2012 Jan;81(1):31-40
Guise CP et al
2012/01/01
Applications: PubMed
67 Narita T et al. Identification of a novel small molecule HIF-1alpha translation inhibitor. Clin. Cancer Res. 2009 Oct;15(19):6128-36
Narita T et al
2009/01/01
Species: Human, Applications: WB PubMed
68 Benito J et al. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS ONE 2011;6(8):e23108
Benito J et al
2011/01/01
PubMed
69 Campanile C et al. Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models. J. Nucl. Med. 2013 Aug;54(8):1362-8
Campanile C et al
2013/01/01
PubMed
70 Muriel L坦pez C et al. Prognostic factors in patients with advanced renal cell carcinoma. Clin Genitourin Cancer 2012 Dec;10(4):262-70
Muriel L坦pez C et al
2012/01/01
Species: Human, Applications: IHC PubMed
71 Li Y et al. Antibody-specific detection of CAIX in breast and prostate cancers. Biochem. Biophys. Res. Commun. 2009 Aug;386(3):488-92
Li Y et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
72 Delhaas T et al. Steep increase in myonuclear domain size during infancy. Anat Rec (Hoboken) 2013 Feb;296(2):192-7
Delhaas T et al
2013/01/01
Species: Human, Applications: IHC, ICC/IF PubMed
73 Melvin A et al. The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH. Mol. Biol. Cell 2011 Nov;22(21):4171-81
Melvin A et al
2011/01/01
Species: Human PubMed
74 F辰hling M et al. Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI. J. Am. Soc. Nephrol. 2013 Nov;24(11):1806-19
F辰hling M et al
2013/01/01
PubMed
75 Arvidsson Y et al. Hypoxia stimulates CXCR4 signalling in ileal carcinoids. Endocr. Relat. Cancer 2010 Jun;17(2):303-16
Arvidsson Y et al
2010/01/01
Species: Human, Applications: IHC PubMed
76 Chen X et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature 2014 Apr;508(7494):103-7
Chen X et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
77 Proescholdt MA et al. Function of carbonic anhydrase IX in glioblastoma multiforme. Neuro-oncology 2012 Nov;14(11):1357-66
Proescholdt MA et al
2012/01/01
Species: Human, Applications: IHC, WB PubMed
78 Cioffi S et al. Tbx1 regulates brain vascularization. Hum. Mol. Genet. 2014 Jan;23(1):78-89
Cioffi S et al
2014/01/01
Species: Mouse, Applications: IHC-Fr, ICC/IF PubMed
79 Baia GS et al. An orthotopic skull base model of malignant meningioma. Brain Pathol. 2008 Apr;18(2):172-9
Baia GS et al
2008/01/01
Species: Mouse, Applications: IHC-P PubMed
80 Zhang M et al. The use of porous scaffold as a tumor model. Int J Biomater 2013;2013:396056
Zhang M et al
2013/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Yoo H et al. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin. Cancer Res. 2007 Jan;13(1):68-75
    Yoo H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sathornsumetee S et al. Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J. Clin. Oncol. 2008 Jan;26(2):271-8
    Sathornsumetee S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kang HJ et al. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma. Virchows Arch. 2015 Jan;
    Kang HJ et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Lin XY et al. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology. Histopathology 2015 Apr;66(5):685-94
    Lin XY et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Motzer RJ et al. Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma. Cancer Chemother. Phar
    Motzer RJ et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gellert LL et al. The diagnostic accuracy of percutaneous renal needle core biopsy and its potential impact on the clinical management of renal cortical neoplasms. Arch. Pathol. Lab. Med. 2014 Dec;138(12):1673-9
    Gellert LL et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Pellegrini L et al. SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ 2012 May;
    Pellegrini L et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Mackenzie KA et al. Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Histopathology 2011 May;58(6):875-85
    Mackenzie KA et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Weber DC et al. The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy. Radiat Oncol 2012;7:66
    Weber DC et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Deschamps L et al. The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum. Neuroendocrinology 2012;95(3):214-22
    Deschamps L et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Lapinski JE et al. Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers. Appl. Immunohistochem. Mol. Morphol. 2010 Oct;18(5):414-21
    Lapinski JE et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Currie MJ et al. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Hum. Pathol. 2012 Oct;
    Currie MJ et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Lee HJ et al. Inhibition of vascular endothelial growth factor a and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int. J. Radiat. Oncol. Biol. Phys. 2015 Mar;91(3):6
    Lee HJ et al
    2015/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Pinato DJ et al. Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations. Br. J. Cancer 2013 Feb;108(2):429-37
    Pinato DJ et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Muriel L坦pez C et al. Predictive factors for response to treatment in patients with advanced renal cell carcinoma. Invest New Drugs 2012 May;
    Muriel L坦pez C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Van den Eynden GG et al. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Br. J. Cancer 2005 Nov;93(10):1128-36
    Van den Eynden GG et al
    2005/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    M端ller J. [Recent evaluation of a Candida hemagglutination test]. Mycoses 1991;34 Suppl 1:63-7
    M端ller J
    1991/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Park I et al. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med 2013 Jul;70(1):33-9
    Park I et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Cho SY et al. Activation of AMP-Activated Protein Kinase α and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells. Evid Based Complement Alternat Med 2013;2013:974313
    Cho SY et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Matsumura Y et al. Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis. Cancer Sci 2012 Mar;
    Matsumura Y et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Dubois L et al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: A new concept of dual targeting drugs. Radiother Oncol 2013 Jul;
    Dubois L et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Garcia-Parra R et al. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Eur. J. Nucl. Med. Mol. Imaging 2011 Oct;38(10):1816-23
    Garcia-Parra R et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Ogino T et al. Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions. Cancer Immunol. Immunother. 2012 Mar;61(3):409-24
    Ogino T et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Onishi H et al. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer. Cancer Sci 2012 Apr;
    Onishi H et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: IHC, ICC/IF
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Pinato DJ et al. An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes. Br. J. Cancer 2014 Jan;110(1):115-22
    Pinato DJ et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Zhang Q et al. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis 2013 Mar;
    Zhang Q et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Santos CD et al. Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma. Br. J. Cancer 2015 Jan;112(1):86-94
    Santos CD et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Piao Y et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro-oncology 2012 Nov;14(11):1379-92
    Piao Y et al
    2012/01/01
  • 備考:
    Species: Human, Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Yin S et al. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP. Clin. Cancer Res. 2012 Dec;18(24):6623-33
    Yin S et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Eguchi D et al. Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. J Surg Res 2012 Jul;
    Eguchi D et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Sadlecki P et al. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients. Biomed Res Int 2014;2014:616850
    Sadlecki P et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Li Y et al. Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells. Biochim. Biophys. Acta 2011 Jan;1813(1):159-67
    Li Y et al
    2011/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Westbury CB et al. Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. Br J Radiol 2007 Nov;80(959):934-8
    Westbury CB et al
    2007/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Carbonell WS et al. β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Res. 2013 May;73(10):3145-54
    Carbonell WS et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P, ICC/IF
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Albert S et al. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Oral Oncol. 2012 Jul;
    Albert S et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Brouillet S et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell. Mol. Life Sci. 2012 Sep;
    Brouillet S et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Wang Y et al. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc. Natl. Acad. Sci. U.S.A. 2012 Mar;109(13):4892-7
    Wang Y et al
    2012/01/01
  • 備考:
    Species: Human, Applications: EMSA, WB
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Jung JH et al. Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer. J. Gastroenterol. 2012 Jan;47(1):37-48
    Jung JH et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Kumar S et al. Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts. Transl Oncol 2013 Aug;6(4):493-503
    Kumar S et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Kwon OJ et al. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma. Head Neck 2014 Feb;
    Kwon OJ et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Chaumeil MM et al. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage 2012 Jan;59(1):193-201
    Chaumeil MM et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Chamboredon S et al. Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells. Mol. Biol. Cell 2011 Sep;22(18):3366-78
    Chamboredon S et al
    2011/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Al-Ahmadie HA et al. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am. J. Surg. Pathol. 2011 Jul;35(7):949-61
    Al-Ahmadie HA et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Lucio-Eterovic AK et al. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin. Cancer Res. 2009 Jul;15(14):4589-99
    Lucio-Eterovic AK et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Pistollato F et al. Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells 2010 Nov;28(11):1918-29
    Pistollato F et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Gauter-Fleckenstein B et al. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. Free Radic. Biol. Med. 2008 Mar;44(6):982-9
    Gauter-Fleckenstein B et al
    2008/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Sakata K et al. Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers. Jpn. J. Clin. Oncol. 2008 Jun;38(6):402-7
    Sakata K et al
    2008/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Speisky D et al. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients. Clin. Cancer Res. 2012 May;18(10):2838-49
    Speisky D et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    El-Heliebi A et al. Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer? J Transl Med 2013;11:214
    El-Heliebi A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Atkins M et al. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin. Cancer Res. 2005 May;11(10):3714-21
    Atkins M et al
    2005/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Wen YA et al. Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells. Mol. Cell. Biol. 2013 Nov;33(22):4594-605
    Wen YA et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Fromy B et al. Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers. Nat Med 2012 Jul;
    Fromy B et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Kato Y et al. Expression of a hypoxia-associated protein, carbonic anhydrase-9, correlates with malignant phenotypes of gastric carcinoma. Digestion 2010;82(4):246-51
    Kato Y et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Kaidi A et al. Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia? Gut 2007 Nov;56(11):1637-8
    Kaidi A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Lim CS et al. Increased activation of the hypoxia-inducible factor pathway in varicose veins. J. Vasc. Surg. 2012 May;55(5):1427-39
    Lim CS et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Janmohamed SR et al. Support for the hypoxia theory in the pathogenesis of infantile haemangioma. Clin. Exp. Dermatol. 2014 Dec;
    Janmohamed SR et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Aarntzen EH et al. Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells. Clin. Cancer Res. 2013 Mar;19(6):1525-1533
    Aarntzen EH et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Loinard C et al. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 2009 Jul;120(1):50-9
    Loinard C et al
    2009/01/01
  • 備考:
    Species: Human, Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Pistollato F et al. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 2010 May;28(5):851-62
    Pistollato F et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Bussolati B et al. Renal CD133+/CD73+ Progenitors Produce Erythropoietin under Hypoxia and Prolyl Hydroxylase Inhibition. J. Am. Soc. Nephrol. 2013 Jul;24(8):1234-41
    Bussolati B et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Ba単uelos CA et al. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation. Clin. Cancer Res. 2009 May;15(10):3344-53
    Ba単uelos CA et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Chen LQ et al. Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models. Leuk. Lymphoma 2014 Nov;:1-8
    Chen LQ et al
    2014/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Chen J et al. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am. J. Pathol. 2009 Jul;175(1):400-11
    Chen J et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Hwa JS et al. The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014 Aug;
    Hwa JS et al
    2014/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Engler JR et al. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. PLoS ONE 2012;7(8):e43339
    Engler JR et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Guise CP et al. Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxia. Mol. Pharmacol. 2012 Jan;81(1):31-40
    Guise CP et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Narita T et al. Identification of a novel small molecule HIF-1alpha translation inhibitor. Clin. Cancer Res. 2009 Oct;15(19):6128-36
    Narita T et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Benito J et al. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS ONE 2011;6(8):e23108
    Benito J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Campanile C et al. Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models. J. Nucl. Med. 2013 Aug;54(8):1362-8
    Campanile C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Muriel L坦pez C et al. Prognostic factors in patients with advanced renal cell carcinoma. Clin Genitourin Cancer 2012 Dec;10(4):262-70
    Muriel L坦pez C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Li Y et al. Antibody-specific detection of CAIX in breast and prostate cancers. Biochem. Biophys. Res. Commun. 2009 Aug;386(3):488-92
    Li Y et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Delhaas T et al. Steep increase in myonuclear domain size during infancy. Anat Rec (Hoboken) 2013 Feb;296(2):192-7
    Delhaas T et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC, ICC/IF
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Melvin A et al. The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH. Mol. Biol. Cell 2011 Nov;22(21):4171-81
    Melvin A et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    F辰hling M et al. Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI. J. Am. Soc. Nephrol. 2013 Nov;24(11):1806-19
    F辰hling M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Arvidsson Y et al. Hypoxia stimulates CXCR4 signalling in ileal carcinoids. Endocr. Relat. Cancer 2010 Jun;17(2):303-16
    Arvidsson Y et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Chen X et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature 2014 Apr;508(7494):103-7
    Chen X et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Proescholdt MA et al. Function of carbonic anhydrase IX in glioblastoma multiforme. Neuro-oncology 2012 Nov;14(11):1357-66
    Proescholdt MA et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC, WB
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Cioffi S et al. Tbx1 regulates brain vascularization. Hum. Mol. Genet. 2014 Jan;23(1):78-89
    Cioffi S et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC-Fr, ICC/IF
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Baia GS et al. An orthotopic skull base model of malignant meningioma. Brain Pathol. 2008 Apr;18(2):172-9
    Baia GS et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Zhang M et al. The use of porous scaffold as a tumor model. Int J Biomater 2013;2013:396056
    Zhang M et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed